These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 16942945)

  • 1. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.
    Waeber B; Mourad JJ
    Am J Hypertens; 2006 Sep; 19(9):985-6. PubMed ID: 16942945
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits and risks of combination therapy in hypertension.
    Node K
    Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
    [No Abstract]   [Full Text] [Related]  

  • 3. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.
    Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent knowledge on the role of diastolic blood pressure in hypertensive patients on treatment].
    Leonetti G; Cuspidi C
    Recenti Prog Med; 2008 Apr; 99(4):191-9. PubMed ID: 18595632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accomplish more blood pressure lowering with initial fixed-dose combination therapy.
    Cardiovasc J Afr; 2009; 20(2):153. PubMed ID: 19421660
    [No Abstract]   [Full Text] [Related]  

  • 6. [Debate on optimal diastolic blood pressure. Does the heart need more than the kidney tolerates?].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):8. PubMed ID: 15219117
    [No Abstract]   [Full Text] [Related]  

  • 7. Systolic hypertension in older persons: how aggressive should treatment be?
    Kapoor JR; Chaudry S; Agostini JV; Foody JA
    Prog Cardiovasc Dis; 2006; 48(6):397-406. PubMed ID: 16714159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fixed-dose combinations in antihypertensive treatment: is it necessary to examine the effectiveness of each component?].
    Dechend R; Derer W; Müller DN
    MMW Fortschr Med; 2009 Nov; 151(45):46-7. PubMed ID: 19960726
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of combination therapy in treatment of hypertension].
    Kreutz R
    Krankenpfl J; 2005; 43(7-10):255. PubMed ID: 16515324
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
    Gradman AH; Traub D
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S22-30. PubMed ID: 17401313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influencing the natural history of hypertension: is it the blood pressure achieved, the drug, or the drug dose?
    Hollenberg NK
    J Hypertens; 2008 Aug; 26(8):1527-32. PubMed ID: 18622224
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-on therapy with a nighttime dose of doxazosin in patients with uncontrolled hypertension: effects on autonomic modulation of the cardiovascular system.
    Guzik P; Wykretowicz A; Krauze T; Piskorski J; Adamska K; Milewska A; Wesseling KH; Wysocki H
    Hypertens Res; 2008 Mar; 31(3):443-53. PubMed ID: 18497463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systolic hypertension.
    Nash DT
    Geriatrics; 2006 Dec; 61(12):22-8. PubMed ID: 17184139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.
    Wald DS; Law M; Morris JK; Bestwick JP; Wald NJ
    Am J Med; 2009 Mar; 122(3):290-300. PubMed ID: 19272490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
    Preston RA; Norris PM; Alonso AB; Ni P; Hanes V; Karara AH
    Menopause; 2007; 14(3 Pt 1):408-14. PubMed ID: 17224857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
    JATOS Study Group
    Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.